Clinical Trial Update: Pioglitazone in Hepatitis C [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pioglitazone for chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Michigan | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED